Skip to main content

NeuroBytes: Anticoagulation Reversal in Intracerebral Hemorrhage

NeuroBytes: Anticoagulation Reversal in Intracerebral Hemorrhage

Course Description

ICH comprises ~15% of strokes but is associated with high mortality and poor functional outcomes. Anticoagulation associated ICH is an increasing concern in an aging US population as the prevalence of atrial fibrillation is projected to rise to 15.9 million patients in 2050. Anticoagulation is associated with hemorrhage expansion and failure to correct coagulopathy is an independent predictor of morbidity and mortality. The aim of this video is to provide insight into reversal of heparin, direct oral anticoagulants (DOACs), and fibrinolytics.

Learning Objectives

As a result of this program the learner will be able to:
  • Describe the mechanism of common anticoagulation medications and the mechanism, indications, and dosing for their respective reversal agents.

Date of Release

November 15, 2023

Confidentiality of Data

All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete Terms of Use.

Faculty & Disclosures

MATTHEW BOWER, MD
Neurocritical Care Fellow
Johns Hopkins Hospital
Baltimore, MD
*Dr. Bower has nothing to disclose.

Editor

SARA STERN-NEZER, MD
Associate Clinical Professor, Neurology
University of California School of Medicine
Irvine, CA
*Dr. Stern-Nezer has nothing to disclose.



Reviewer

CALLI LEIGHANN COOK, DNP, FNP-C
Clinical Assistant Professor, Emory Nell Hodgson
Woodruff School of Nursing
Nurse Practitioner, Emory Brain Health Center
Atlanta, GA
*Dr. Cook has nothing to disclose.



Voiceover Artist

Tessa Dahlgren
eLearning Production Program Manager
American Academy of Neurology
Minneapolis, MN
*Ms. Dahlgren has nothing to disclose.


NeuroBytes Staff

Xiaoyu Sun, Associate Director, eLearning
Minneapolis, MN
*Ms. Sun has nothing to disclose.


Zach Cramer, Program Manager, eLearning
Minneapolis, MN
*Mr. Cramer has nothing to disclose.


Sulia Altenberg, eLearning Coordinator
Minneapolis, MN
*Ms. Altenberg has nothing to disclose.

*Relationship Disclosure